SBI Securities »

Unicycive Therapeutics shares owned by SBI Securities

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by SBI Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4k 560 4.36
2025-06-30 $2.6k 553 4.77

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Tesla Motors (TSLA)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
Vanguard Total World Stock ETF Etf (VT)
Amazon (AMZN)
Vanguard High Dividend Yield ETF Etf (VYM)
Alphabet Inc Class A cs (GOOGL)
SPDR Portfolio S&P500 HighDividend ETF Etf (SPYD)
Facebook Inc cl a (META)
Direxion Daily Semi Bull 3X Etf (SOXL)

View all positions for SBI Securities

Top funds holding Unicycive Therapeutics

Vivo Capital
Octagon Capital Advisors
Nantahala Capital Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Logos Global Management
Geode Capital Management
Squarepoint Ops
Longwood Capital Partners
State Street Corporation
Goldman Sachs Group
Citadel Advisors
XTX Topco
BlackRock
Northern Trust

View all funds holding Unicycive Therapeutics